from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0010c/-

LFCtreatmentdescriptionclass of inhibitor

0.242

Amikacinug/mL Amikacintranslation

-0.552

Cap5-10ug/mL Capreomycintranslation

-0.216

Rox10-50 ug/mL Roxithromycintranslation

0.637

SM2-5 ug/mL Streptomycintranslation

0.893

Tet5-10 ug/mL Tetracyclinetranslation

0.859

Rif0.2-5ug/mL Rifampicintranscription

-0.084

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.644

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.250

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.716

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.483

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.473

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.012

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.275

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.278

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.040

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.605

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.871

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.117

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.216

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.632

KCN5-20 ug/mL Potassium cyaniderespiration

-0.527

NaN30.2-2 mM Sodium aziderespiration

-0.497

Nigericin50 uM Nigericinrespiration

-0.356

TRC10-150 ug/mL Triclosanrespiration

-1.918

TRZ10-25 ug/mL Thioridazinerespiration

-0.195

Valinomycin0.5-10 uM Valinomycinrespiration

0.410

ZnSO42 mM ZnSO4respiration

-1.016

menadione6-10 ug/mL Menadionerespiration

-0.354

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.316

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.067

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.060

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.118

NRP_1Non-replicating persistence stage 1dosRassociated

-0.089

Amp0.2mg/mL AmpicillincellWall

0.099

Cephalexin20-100 ug/mL CephalexincellWall

0.548

Cerulenin0.32-5 ug/mL CerulenincellWall

0.423

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.247

EMB10-20 ug/mL EthambutolcellWall

-0.125

Eta12-40 ug/mL EthionamidecellWall

0.344

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.756

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.228

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.448

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.205

BZA0.12 mg/mL BenzamidearomaticAmides

0.581

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.288

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.302

H2O24 mM hydrogen peroxideDNAdamaging

0.086

Levo10 ug/mL LevofloxacinDNAdamaging

0.678

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.531

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.145

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.487

UVUV-irradiationDNAdamaging

-0.212

ARP41-4 ug/mL Antitubercular compound ARP4?

0.070

Antimycin12.5-50 ug/mL Antimycin A?

-0.250

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.474

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.329

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.083

PA8240.2-2 ug/mL PA-824?

0.496

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.715

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.003

Verapamil50 uM Verapamil?

-0.261

mercaptoethanol2 mM 2-Mercaptoethanol?

0.062

methoxatin10-20 ug/mL Methoxatin?